辉瑞、默沙东都在扫货。文|张羽岐编辑|温斯婷来源|时代财经APP(ID:tf-app)头图来源|AI生成以2015年药品审评审批制度改革为起点,过去十年堪称是中国医药史上变革最为迅速的十年。这十年间,中国创新药开始从本土走向世界,在创新动能与政策红利的双重驱动下,全球医药产业正加速迎来“中国时刻”。根据中邮证券研报,2025年上半年,中国创新药License-out(许可授权)总金额已接近660...
Source Link辉瑞、默沙东都在扫货。文|张羽岐编辑|温斯婷来源|时代财经APP(ID:tf-app)头图来源|AI生成以2015年药品审评审批制度改革为起点,过去十年堪称是中国医药史上变革最为迅速的十年。这十年间,中国创新药开始从本土走向世界,在创新动能与政策红利的双重驱动下,全球医药产业正加速迎来“中国时刻”。根据中邮证券研报,2025年上半年,中国创新药License-out(许可授权)总金额已接近660...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.